Laura Bohrer

PhD

B.A., Biology/Biochemistry, Wartburg College
Ph.D., Cancer Biology, University of Nebraska Medical Center
Postdoctoral Training, Cancer Biology, University of Minnesota

Laura had 12+ years in cancer-related research throughout her PhD and postdoctoral training before joining the Wiley Lab in Fall 2016. Her current work is focused on the differentiation of human induced pluripotent stem cells (iPSCs) into corneal endothelial cells for the study and treatment of Fuchs endothelial corneal dystrophy. She also has ongoing collaborations with the Tucker Stem Cell Lab investigating the use of CRISPR-Cas9-mediated genome editing to correct patient-derived iPSCs harboring mutations in the genes CLN3 and NR2E3, among others.